 There are several ways that active targeting can be accomplished.One way to actively target solely diseased tissue in the body is to know the nature of a receptor on the cell for which the drug will be targeted to.Researchers can then utilize cell-specific ligands that will allow the nanoparticle to bind specifically to the cell that has the complementary receptor.